Smithfield, R.I.
Rubius Therapeutics began construction in October of 2018 on a $155 million pharmaceutical manufacturing plant in Smithfield, R.I. The project includes renovation of an existing 135,000-sf building to create a leading-edge facility for the manufacture of the company's Red Cell Therapeutics product line which includes treatments for cancer and other diseases. The structure, which was formerly owned and occupied by Alexion, will accommodate 160 new employees.
Source
